A marker for Stevens-Johnson syndrome ...: ethnicity matters.
about
Toxic epidermal necrolysis and Stevens-Johnson syndromeDrug induced exfoliative dermatitis: state of the artNew genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityIdiosyncratic adverse drug reactions: current conceptsSevere Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical ImplementationThe Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian SubjectsComparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug ReactionsDistributions of HLA-A and -B alleles and haplotypes in the Yi ethnic minority of Yunnan, China: relationship to other populationsGenome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in EuropeWhat are our AIMs? Interdisciplinary Perspectives on the Use of Ancestry Estimation in Disease Research.Expectations, validity, and reality in pharmacogenetics.The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective reviewAbsence of HLA-B*1502 and HLA-A*3101 alleles in 9 Korean patients with antiepileptic drug-induced skin rash: a preliminary study.Pharmacogenetics of drug hypersensitivity.HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in EuropeansGenome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.Problems with the collection and interpretation of Asian-American health data: omission, aggregation, and extrapolationClinical application of pharmacogenomics.Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.Drug hypersensitivity: pharmacogenetics and clinical syndromes.Epidemiology and risk factors for drug allergy.PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.HapMap, pharmacogenomics, and the goal of personalized prescribingBibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015Antecedent Drug Exposure Aetiology and Management Protocols in Steven-Johnson Syndrome and Toxic Epidermal Necrolysis, A Hospital Based Prospective StudySystems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms.Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.A case of mexiletine-induced hypersensitivity syndrome presenting as eosinophilic pneumonia.Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective.The emerging era of pharmacogenomics: current successes, future potential, and challenges.Genomic architecture of pharmacological efficacy and adverse events.Early toxic epidermal necrolysis syndrome post-intra-cranial tumor resection.Recent advances in the understanding of severe cutaneous adverse reactions.Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screeningThe p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors.Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.PharmGKB summary: carbamazepine pathway.
P2860
Q21202877-CBCC4252-D955-4912-8DA4-3A3D1BC6F676Q26739886-3A81C05F-5F0F-4F3C-BDDC-DC448250AAC5Q26800976-511D6DA3-7061-44D9-92CF-6A8072D5159EQ26824391-5ED8FFBF-F7C0-43E2-A4D7-E397586D157DQ28076600-852F5131-C96C-4E9E-9E0F-7342BF525170Q28547386-AD7FA7A8-C224-43BC-AEFB-ED786817494CQ28552275-756A74DA-D0DF-4177-9587-23AE42EC1F4CQ28749095-7B445991-2ACC-43B6-B7BD-D9A1D8B7D09FQ28943413-67521147-DD9F-4B40-A1D1-44B1AF0094FAQ30600102-6D0E506F-6D1D-47C5-8A71-C5A59D7BC49EQ33926313-60A8945D-5C2C-448C-AC34-59D92B1E8814Q34016198-CB484C20-4EF9-4416-83E8-5377C5E3EC85Q34116637-326B3F6C-4815-4065-A847-09B1BC6ED8A0Q34118186-4D0E4202-18E8-495F-8033-DF244B07528BQ34172669-6FD0AF3A-8E71-4436-BC7F-04E3CA083AD6Q34257932-273DD514-D742-42EC-B22C-EDA4E6D806C6Q34280673-07B56300-EE9F-4536-9DA0-B17343C16781Q34280685-610B789D-B07E-48DF-A59E-872370611E18Q34345953-01AFFA04-C87C-42B9-9E3C-AD3C715DF163Q34598487-C1A11959-8DF6-4A97-B1C9-F7E251F967B1Q34701492-2461E019-48C3-4CDA-B1C3-24057B0CD38DQ34976470-41F6073A-5462-4E68-8698-063443E8E590Q35168561-BC01B6D5-DF58-4E45-94B8-0FF047F1E2F1Q35827699-A7EDD4AD-D682-4EA9-ABD7-BE7A26E87C2AQ36253270-C6721158-3771-44E8-A271-A1376F8C2791Q36541832-7BDF13F6-B2E4-4563-90D0-4FF9D5B3C8F5Q36599215-82C6B29C-EEBA-4CC4-9BBE-B6B7A9784E26Q36603317-751AAFC9-F842-4CE1-BEE8-EEB952895062Q37033603-2B84A3FE-21CC-41F2-A932-548EE61EB608Q37341208-CD3281BE-C813-484A-AEFF-AE9E1E79B4C4Q37669205-12F9F594-B0A8-4751-B2A7-7C9F09C67F60Q38164730-03C97BB1-3DA9-4F75-B58B-B7645BDC6E8CQ38200683-2746E8FF-ABF6-4D77-8C40-905ED6D83B43Q38292930-DFF5A8EB-BA05-4387-B73C-158254987BE2Q38667195-8AC3B833-FE3A-4FC4-A1AD-1D177F02542AQ38931289-2805D1CF-6199-48D3-A9C0-251B39CC2C63Q39729427-BFF18CD8-7572-4B1F-BC63-1B2FE90C206DQ40619738-FC0FF69E-05BD-43EF-966E-DFCD4208875DQ41494133-CD31853E-1403-4DE5-A1E3-04A15D2AF27BQ42157342-3A7E7109-B2A0-4F59-84AA-50B6581D474E
P2860
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@ast
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@en
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@nl
type
label
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@ast
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@en
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@nl
prefLabel
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@ast
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@en
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@nl
P2093
P2860
P356
P1476
A marker for Stevens-Johnson syndrome ...: ethnicity matters.
@en
P2093
J-C Roujeau
M Mockenhaupt
M Schumacher
RegiSCAR Group
P2860
P2888
P304
P356
10.1038/SJ.TPJ.6500356
P577
2006-01-17T00:00:00Z
P5875
P6179
1050700804